Determining how to utilize new treatments for complement 3 glomerulopathy

NEW ORLEANS — In this video from the National Kidney Foundation Spring Clinical Meetings, Paolo Cravedi, MD, PhD, discusses the treatment landscape in complement 3 glomerulopathy.
Cravedi, professor in the division of nephrology at the Icahn School of Medicine at Mount Sinai, highlights the effectiveness of new treatments for complement 3 glomerulopathy in both transplant and native cases.
“The challenge is how to use these treatments, for how long, [and] whether should we use them to prevent the disease recurrence in the transplant or after the disease has recurred,” Cravedi








